Skip to content

Clinical trials

Completed Phase 4 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 4 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20062
20072
20101
20121
20141
20151
20182
20193
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
PETHEMA Foundation2
Amgen1
Amsterdam UMC, location VUmc1
CASI Pharmaceuticals (China) Co., Ltd.1
Centre Hospitalier Universitaire de Nice1
Columbia University1
Gregory Piazza1
Johnson & Johnson Private Limited1
Johnson & Johnson Taiwan Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma22
Bone Neoplasms2
Breast Neoplasms2
Lymphoma, Non-Hodgkin2
Prostatic Neoplasms2
Recurrence2
Anemia1
Back Pain1
Blast Crisis1
Bone Diseases, Metabolic1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.